§ 74-52 — Restrictions on biotechnology equipment and services for

state agencies. A. For purposes of this section: 1. “Biotechnology company of concern” means an entity designated by the federal government to be under the control of a foreign adversary and that poses a risk to national security based on the company’s research of multiomic data collection; and 2. “Multiomics” means a biological analysis method that combines data from multiple research areas, including, but not limited to, genomics, transcriptomics, proteomics, epigenomics, and metabolomics in order to gain a comprehensive understanding of complex biological processes. B. Any state agency that receives federal or state funds shall not be authorized to use or procure any biotechnology equipment or service that originates from a company designated by the federal government to be a biotechnology company of concern nor shall any such state agency contract with an entity that uses or procures such biotechnology.

Legislative History

Added by Laws 2025, c. 39, § 1, cont. eff. (see Note). NOTE: Laws 2025, c. 39, § 2, provides: "This act shall take effect upon the enactment of a federal law that prohibits entities that receive federal funds from using biotechnology that is from a company associated with a foreign adversary."